<code id='A455E628D9'></code><style id='A455E628D9'></style>
    • <acronym id='A455E628D9'></acronym>
      <center id='A455E628D9'><center id='A455E628D9'><tfoot id='A455E628D9'></tfoot></center><abbr id='A455E628D9'><dir id='A455E628D9'><tfoot id='A455E628D9'></tfoot><noframes id='A455E628D9'>

    • <optgroup id='A455E628D9'><strike id='A455E628D9'><sup id='A455E628D9'></sup></strike><code id='A455E628D9'></code></optgroup>
        1. <b id='A455E628D9'><label id='A455E628D9'><select id='A455E628D9'><dt id='A455E628D9'><span id='A455E628D9'></span></dt></select></label></b><u id='A455E628D9'></u>
          <i id='A455E628D9'><strike id='A455E628D9'><tt id='A455E628D9'><pre id='A455E628D9'></pre></tt></strike></i>

          explore

          explore

          author:hotspot    Page View:56456
          Cynthia Fisher on stage at the 2023 STAT Summit.
          Cynthia Fisher, founder and chairman, PatientRightsAdvocate.org STAT

          BOSTON — For all those who think hospital price transparency will not save money, Cynthia Fisher has a message: it’s already doing so.

          Fisher, who spoke Wednesday at the annual STAT Summit in Boston, is the successful entrepreneur and founder of PatientRightsAdvocate.org who has been leading an unorthodox campaign to get hospitals to disclose prices.

          advertisement

          The campaign has made progress. Republicans on three House committees introduced a bill to make hospitals disclose prices up front, though then-House Speaker Kevin McCarthy (R-Calif.) pulled the bill shortly before it was supposed to receive a vote on the House floor.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Novavax promises a turnaround & Lilly roils the obesity market
          Novavax promises a turnaround & Lilly roils the obesity market

          SammyKimballforSTATCanNovavaxfinallygetitright?What’sa“triple-G”drug?AndisNovoNordisklosingground?We

          read more
          JPM 2024: Verve Therapeutics looks to mainstream genome editing
          JPM 2024: Verve Therapeutics looks to mainstream genome editing

          VerveTherapeuticsCEOSekarKathiresanVerveSANFRANCISCO—Thepromiseofgenomeeditinghasgivenrisetopotentia

          read more
          Drug repurposing or repositioning? The language matters
          Drug repurposing or repositioning? The language matters

          AdobeFindinganewmedicineisnevereasy.Butdevelopingtreatmentsforpatientswithrarediseases—conditionstha

          read more

          Readout LOUD podcast: 2023 in review, and a look at biotech in 2024

          WhatdoesitmeantoabadCEO?Canbiotechendureanotherelectionyear?AndcanyougototoomanyJ.P.Morganparties?We